Document is current
Any future updates will be listed below
-
Authors
Maraux, Mélissa https://orcid.org/0000-0001-6120-796X
Vetter, Mathieu https://orcid.org/0009-0001-3019-354X
Zuffo, Ludivine Dal
Bonnefoy, Francis
Wetzel, Audrey
Varin, Alexis
Lamarthée, Baptiste
Tassy, Olivier
Ducloux, Didier
Saas, Philippe https://orcid.org/0000-0002-8857-9939
Cherrier, Thomas https://orcid.org/0000-0002-0707-9204
-
Funding
Funding for this research was provided by:
Agence Nationale de la Recherche (ANR-11-LABX-0021-LipSTIC, ANR-11-LABX-0021-LipSTIC, ANR-11-LABX-0021-LipSTIC)
- License Information
-
More Information
Article History
Received: 16 January 2025
Revised: 27 June 2025
Accepted: 21 July 2025
First Online: 28 August 2025
Ethical approval
: Human samples used in in vitro experiments were obtained from healthy donors of the French Blood Agency (EFS Bourgogne Franche-Comté, Besançon, France), following consent signature (authorization number #AC-2015-2408). Informed consent was obtained from all subjects involved in the clinical trial NCT05106075 supported by the CHRU of Besançon. All in vivo experimental studies complied with European legislation and were approved under project #2019-001-SP-7PR by the Animal Ethics Committee of Besançon (Comité d’Ethique Bisontin en Experimentation Animale #58) and the French Ministry of Higher Education, Research and Innovation, both authorities for the care and use of animals. All methods were performed in accordance with the relevant guidelines and regulations.
: The authors declare no competing interests.
